The Infliximab for Injection, cataloged under National Stock Number 6505-01-690-4043, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 3 specifications, cited from the U.S. Government catalog. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-690-4043 |
| Item Name | Infliximab for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Administration | INTRAVENOUS INFUSION |
| Primary Container Content Quantity | 10.0 MILLILITERS AFTER RECONSTITUTION |
| Primary Container Type | VIAL |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Reference | Meaning |
|---|---|
| 1580055 | 5/1 Secondary reference U.S. Government activity |
| NDC00069-0809-01 | 3/2 Design control — primary reference U.S. Government activity |
| 6505NCM206405 | 5/1 Secondary reference Defense Medical Standardization Board |
| INFLECTRA | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-690-4043 is a Infliximab for Injection, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-690-4043: Administration: INTRAVENOUS INFUSION; Primary Container Content Quantity: 10.0 MILLILITERS AFTER RECONSTITUTION; Primary Container Type: VIAL; Special Features: INLFLECTRA IS A TISSUE NECROSIS FACTOR (TNF) BLOCKER INDICATED FOR CROHN'S DISEASE TO REDUCE THE SIGNS AND SYMPTOMS AND INDUCING AND MAINTAINING CLINICAL REMISSION IN ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE DISEASE WHO HAVE HAD AN INADEQUATE RESPONSE TO CONVENTIONAL THERAPY; THE LYOPHILIZED FORMULATION NEEDS TO BE RECONSTITUTED WITH 10 ML OF STERILE WATER PRIOR TO USE; PACKAGED AS 100 MG; INTENDED FOR INTRAVENOUS INFUSION ONLY; SINGLE-USE VIAL; DISCARD UNUSED PORTION; CONCENTRATION OF FINAL SOLUTION 10MG/1ML; MUST BE REFRIGERATED AT 2 C TO 8 C (36 F TO 46 F); DO NOT USE INFLECTRA BEYOND THE EXPIRATION DATE; THIS PRODUCT CONTAINS NO PRESERVATIVE.. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.